You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
21 January 2026 - Biopharmaceutical company Avacta Group PLC (AIM: AVCT) announced on Wednesday that it has received clearance from the U.S. Food and Drug Administration of the Investigational New Drug application for FAP-Exatecan (AVA6103), the comp...
21 January 2026 - Danish pharmaceutical company LEO Pharma A/S said on Wednesday that it has initiated the phase 3 DELTA CARE 1 trial to evaluate the efficacy and safety of Anzupgo (delgocitinib) cream versus cream vehicle in adults with mild to seve...
21 January 2026 - Insilico Medicine (HKEX: 3696), a Hong Kong-based clinical-stage biotechnology company that utilises generative artificial intelligence (AI), announced on Tuesday that it has signed a co-development collaboration agreement with Hygt...
21 January 2026 - HistoIndex, a Singapore-based developer of AI-driven digital pathology solutions for chronic liver disease, said on Tuesday that it has formed a strategic partnership with Houston Research Institute (HRI), a US research institute fo...
20 January 2026 - UK biopharmaceutical company GSK plc (LSE/NYSE: GSK) on Tuesday announced a definitive agreement to acquire RAPT Therapeutics (NASDAQ:RAPT), a California-based clinical-stage biopharmaceutical company, in a transaction valued at app...
20 January 2026 - German biopharmaceutical company Boehringer Ingelheim announced on Monday that the US Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) Chewable Tablets and VETMEDIN Solution (pimobendan oral solution), for the d...
19 January 2026 - Precision oncology company Guardant Health Inc (Nasdaq: GH) announced on Monday that it has entered into a multi-year strategic collaboration with pharmaceutical firm Merck, known as MSD outside the United States and Canada, to supp...